Facebook icon Twitter icon Forward icon

'Smart' insulin automatically adjusts blood sugar in mice

Scientists have developed a “smart” insulin that self-activates in response to blood sugar levels, according to new research.

The new compound developed by scientists from the University of Utah automatically activates when blood sugar levels soar, and remains in circulation for up to 24 hours.

When blood sugar is high, the insulin becomes active, working quickly to normalise blood sugar levels. One injection of the smart insulin, called Ins-PBA-F, can repeatedly and automatically normalise blood sugar levels over a minimum of 14 hours in mice with a Type 1 diabetes-like condition, according to a study published on Monday in PNAS Early Edition.

To read more, click here.

Supplies appeal for Ghanaian diabetes clinics

A Diabetes Specialist Nurse who organises clinics in Ghana in her spare time is appealing for medical equipment.

Anna Vanderpuye, from London’s Kings College Hospital, is looking for insulin, test strips, blood glucose monitors, a HbA1c monitor and a cholesterol testing kit for her ‘Diabetes Health Days’. To read more, click here.

'We're not trying to cheat the system, we need medication to survive'

“Diabetes is a lifelong condition that causes a person’s blood sugar level to become too high” – NHS Choices.

Yes, diabetes is a lifelong condition, the NHS clearly states that message. Healthcare professionals break that jaw-dropping news to us and our families when we are diagnosed, we read about it in the papers, it stays in our minds with every injection, cannula change and finger-prick test we do, and we have no way of getting away from this incurable condition that we live with day in and day out. To read more, click here.

Glucose monitoring on new Apple watch app

An app is being developed to allow people with diabetes to check their blood sugar levels on Apple’s new smart watch.

It will enable people to share their blood sugar information with others who also have an Apple Watch or an iPhone. To read more, click here.

Inhaled insulin now available in US

An inhaled insulin has gone on sale in America this month.

Afrezza, developed by MannKind and licensed to pharmaceutical company Sanofi, is available in the US market for people with Type 1 or Type 2 diabetes on prescription as a bolus insulin. To read more, click here.